Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

StemCells Inc (NASDAQ:STEM)

1.56
Delayed Data
As of Aug 25
 -0.04 / -2.50%
Today’s Change
0.33
Today|||52-Week Range
7.56
-68.79%
Year-to-Date
StemCells (STEM) Stock Plummets, CEO, CFO Resign
Aug 17 / TheStreet.com - Paid Partner Content
StemCells (STEM) Stock Skyrockets on Microbot Medical Merger
Aug 16 / TheStreet.com - Paid Partner Content
One Reason Why StemCells (STEM) Stock Is Down Today
Aug 17 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close1.60
Today’s open1.60
Day’s range1.53 - 1.67
Volume1,929,408
Average volume (3 months)2,222,452
Market cap$19.2M
Dividend yield--
Data as of 3:59pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)+28.23%
Earnings growth (this year)+42.11%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-88.45%
P/E ratioNM
Price/Sales341.39
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DRIODarioHealth Corp-0.07-2.18%
SNGXSoligenix Inc-0.02-3.01%
MATNMateon Therapeutics ...-0.00-0.30%
CSBRChampions Oncology I...-0.03-1.62%
Data as of 3:59pm ET, 08/25/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$116.9K
Annual profit (last year)-$36.4M
Net profit margin-31,154.04%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Secretary &
General Counsel
Ken Stratton
EVP-Scientific &
Strategic Alliances
Ann Tsukamoto
Corporate headquarters
Newark, California

Forecasts

Partner Offers

Search for Jobs